Manufacturer: Intas Pharmaceuticals Ltd
Salt Composition : Ranibizumab(2.3mg)
Razumab 2.3mg Injection is administered directly into the eyeball by an eye specialist. You should not self administer this medicine at home. The common side effects include conjunctival hemorrhage, eye pain, eye floaters, increased intraocular pressure, and eye inflammation.
However, if you experience these side effects for a longer duration or any other symptoms which you think may be due to this medicine, please inform your doctor. It is not advised to drive after administration of this injection as it may cause blurring of vision.
Razumab 2.3mg Injection is an anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the growth and leakage of abnormal blood vessels in the eye(s) that may cause vision loss.
Ranibizumab binds to the receptor-binding site on VEGF-A, which inhibits the binding of VEGF molecules to their receptors on the surface of endothelial cells. 3,6 Ranibizumab blocks all isoforms of VEGF-A.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Razumab
Conjunctival hemorrhage
Eye pain
Increased intraocular pressure
Foreign body sensation in eyes
Blurred vision
Nausea
Dry eye
Eye itching
Cataract
Vitreous floaters
Vitreous detachment
Intraocular inflammation
Eye irritation
Increased lacrimation
Eyelid inflammation
Ocular hyperemia
Retinal disorder
Maculopathy
Eye discomfort
Posterior capsule opacification
Injection site hemorrhage
Nasopharyngitis (inflammation of the throat and nasal passages)
Anemia (low number of red blood cells)
Joint pain
Renal failure
Peripheral neuropathy (tingling and numbness of feet and hand)
Gastro-esophageal reflux disease
Hypercholesterolemia (high cholesterol)
Bronchitis (inflammation of the airways)
Contraindications include ocular or periocular infections and hypersensitivity. [22] Patients who have an ocular infection, who recently underwent ocular surgery, or have increased intraocular pressures should avoid ranibizumab use.
Razumab 2.3mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
It is not known whether it is safe to consume alcohol with Razumab 2.3mg Injection. Please consult your doctor.
Razumab 2.3mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
(ranibizumab injection) is indicated for the treatment of patients with: Neovascular (wet) age-related macular degeneration (wAMD) Macular edema following retinal vein occlusion (RVO) Diabetic macular edema (DME)
Drug-Drug Interactions: Inform the doctor if you are using, have recently used or might use any other medicines.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Inform the doctor if you have/had an eye infection, eye inflammation, or stroke.
Kindly do not self administer.
Store in a refrigerator (2 - 8°C). Do not freeze.
If you miss a dose of Razumab 2.3mg Injection, please consult your doctor.\n
Consult a doctor before taking any medicines.
It may cause temporary visual disturbances. Don't drive or do anything that requires mental focus until you know how Razumab 2.3mg Injection affects you.
Inform your doctor if you experience increased eye pain and redness, blurred or decreased vision, or increased sensitivity to light.
Wear sunglasses if your eyes feel sensitive to light
Use eye drops if they are prescribed to you by your doctor.
Ask your doctor if you should avoid any particular activities.
Try to rest your eyes as much as possible (for at least a few hours).
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Q. Who should not take Razumab 2.3mg Injection?
Razumab 2.3mg Injection should not be taken by individuals who are allergic to the medication or have an active eye infection.
Q. What is the duration of treatment for Razumab 2.3mg Injection?
Razumab 2.3mg Injection is recommended to be initially administered by intravitreal injection (into the eye) once a month (approximately 28 days) for up to 3 months.
Q. What precautions should I take after taking Razumab 2.3mg Injection?
After taking Razumab 2.3mg Injection:<br>a. You should not wash your face and hair or shower for 48 hours<br>b. Avoid rubbing your eyes<br>c. Avoid swimming for a week. Consult your doctor in case of any doubts<br>d. Do not wear contact lenses immediately after injection. You may wear spectacles instead<br>e. Give complete rest to your eyes and do not strain by looking at television, mobile phones, or computer screens for 1-2 days.
